Palatin Technologies【PTN】株式ニュース

名称	銘柄コード	市場	種別
Palatin Technologies Inc New	PTN	AMEX	普通株式

	前日比	前日比 %	現在値	時刻
	-0.06	-3.06%	1.90	07:42:09

始値	安値	高値	終値	前日終値
2.00	1.9612	2.13	2.04	1.96

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/15	21:40	EDGAR2	Form 8-K - Current report
2024/5/15	21:04	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/15	20:30	PRNUS	Palatin Reports Third Quarter Fiscal Year 2024 Financial..
2024/5/09	20:30	PRNUS	Palatin to Report Third Quarter Fiscal Year 2024 Results;..
2024/5/02	20:30	PRNUS	Palatin Announces FDA Clearance of IND Application for the..
2024/4/30	20:30	PRNUS	Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple..
2024/4/08	20:30	PRNUS	Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease..
2024/3/08	07:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/05	02:57	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/28	21:30	PRNUS	Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3..
2024/2/15	23:00	EDGAR2	Form 8-K - Current report
2024/2/15	21:30	PRNUS	Palatin Reports Second Quarter Fiscal Year 2024 Financial..
2024/2/15	06:17	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/15	04:55	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/09	21:30	PRNUS	Palatin to Report Second Quarter Fiscal Year 2024 Results;..
2024/2/05	21:30	PRNUS	Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal..
2024/2/02	07:16	EDGAR2	Form 8-K - Current report
2024/2/02	06:00	PRNUS	Palatin Announces Closing of $10 Million Registered Direct..
2024/1/30	22:00	PRNUS	Palatin Announces $10 Million Registered Direct Offering
2024/1/09	00:33	PRNUS	Palatin Provides Corporate Update and Highlights Strategic..
2024/1/03	22:00	BW	Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide..
2023/12/20	23:00	EDGAR2	Form 8-K - Current report
2023/12/20	21:30	PRNUS	Palatin Completes Sale of Vyleesi® to Cosette..
2023/12/19	06:45	EDGAR2	Form 8-K - Current report
2023/12/19	06:15	PRNUS	Palatin Receives Notice of Acceptance of the Listing..
2023/12/18	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2023/12/09	07:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/07	07:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/07	04:25	EDGAR2	Form 144 - Report of proposed sale of securities
2023/12/05	07:00	EDGAR2	Form S-1 - General form for registration of securities under..
2023/12/02	05:52	EDGAR2	Form 144 - Report of proposed sale of securities
2023/11/14	21:30	PRNUS	Palatin Reports First Quarter Fiscal Year 2024 Financial..
2023/11/09	21:30	PRNUS	Palatin to Report First Quarter Fiscal Year 2024 Results;..
2023/10/25	05:50	PRNUS	Palatin Announces Closing of $5 Million Registered Direct..
2023/10/25	05:05	EDGAR2	Form 8-K - Current report
2023/10/23	20:30	PRNUS	Palatin Announces $5 Million Registered Direct Offering
2023/10/19	21:01	EDGAR2	Form 8-K - Current report
2023/10/19	20:30	PRNUS	Palatin Announces Preliminary Quarter Ended September 30,..
2023/10/18	20:30	PRNUS	Palatin Announces Positive Preclinical Data Showing..
2023/10/16	20:30	PRNUS	Palatin Presents Data at the United European..
2023/10/14	05:31	EDGAR2	Form 8-K - Current report
2023/10/14	05:15	PRNUS	Palatin Receives Notice of Non-Compliance from NYSE American
2023/9/28	21:02	EDGAR2	Form 8-K - Current report
2023/9/28	21:00	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/9/28	20:30	PRNUS	Palatin Reports Fourth Quarter and Fiscal Year Ended 2023..
2023/9/23	05:00	PRNUS	Palatin to Report Fourth Quarter and Fiscal Year End 2023..
2023/9/08	21:00	EDGAR2	Form 8-K - Current report
2023/9/08	05:00	PRNUS	Palatin to Present at the H.C. Wainwright 25th Annual Global..
2023/9/07	21:49	EDGAR2	Form 8-K - Current report
2023/9/07	20:30	PRNUS	Palatin Completes Enrollment in Phase 3 MELODY-1 Study of..